Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quintiles’ aims to raise $600m in IPO, but who else will sell?

This article was originally published in Scrip

Executive Summary

In a recent interview with Scrip, Dr Dennis Gillings, executive chairman and founder of Quintiles, waxed lyrical about the "luxury" of being a private company. However, according to the registration statement it filed with the US Securities and Exchange Committee (SEC) to raise $600 million in an initial public offering of common stock, the time has come to go public once again.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC020433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel